Skip to main content

Table 1 Overview on baseline characteristics of the patients in the study

From: Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients

Characteristic

Training Set

(N = 313)

Validation Set

(N = 165)

Gender (%)

 Male

187(59.7)

79(47.9)

 Female

126(40.3)

86(52.1)

Age, years, mean ± SD

59.20 ± 12.14

66.54 ± 12.90

DFS,months, mean ± SD

DFS status

44.96 ± 17.12

59.4 ± 26.02

 Relapse

46(14.7)

20(12.1)

 Non-relapse

267(85.3)

145(87.9)

Adjuvant chemotherapy (%)

 Without ACT

97(31.0)

 With ACT

216(69.0)

Radiomics score, mean ± SD

0.1464 ± 0.0843

0.1535 ± 0.0824

  1. Baseline characteristics of the patients